Human Cord Blood-Derived Unrestricted Somatic Stem Cell Infusion Improves Neurobehavioral Outcome in a Rabbit Model

Govindaiah Vinukonda1,2, Yanling Liao1, Furong Hu1

  • 1Department of Pediatrics, New York Medical College, Valhalla, New York, USA.

Insights

Unrestricted somatic stem cells (USSCs) show promise in treating preterm birth complications like intraventricular hemorrhage (IVH). USSC treatment reduced inflammation and improved white matter integrity and neurobehavioral outcomes in rabbit pups.

Area of Science:

  • Neonatal Neurology
  • Stem Cell Therapy
  • Neuroinflammation

Background:

  • Intraventricular hemorrhage (IVH) is a major complication of preterm birth with no cure, leading to severe neurological deficits.
  • Unrestricted somatic stem cells (USSCs) demonstrate reparative potential in preclinical models of central nervous system injury.

Purpose of the Study:

  • To evaluate the efficacy of USSCs in mitigating white matter damage and improving neurobehavioral outcomes in a rabbit model of IVH.
  • To compare the effects of intracerebroventricular (ICV) versus intravenous (IV) administration of USSCs.

Main Methods:

  • Premature rabbit pups received glycerol-induced IVH and were treated with USSCs via ICV or IV routes 24 hours post-injury.
  • Cell distribution, white matter integrity, glial activation, apoptosis, cytokine levels, and neurobehavioral performance were assessed at postnatal days 3, 7, and 14.
  • In vivo bioluminescence imaging and immunohistochemistry were employed.

Main Results:

  • USSCs were detected in the injured parenchyma (IV route) and adjacent to ventricles (ICV route) without adverse events.
  • USSC treatment attenuated microglial infiltration, reduced apoptotic cell death, and decreased reactive astrocytes and inflammatory cytokines (TNFα, IL1β).
  • Treated animals showed improved myelin preservation, increased myelin gene expression, and enhanced locomotor function.

Conclusions:

  • USSCs exert significant anti-inflammatory effects in the context of IVH, mitigating key pathological consequences.
  • Both IV and ICV administration routes showed therapeutic potential, with IV cells distributing more widely in the parenchyma.
  • USSC therapy represents a promising strategy for managing neurological damage associated with intraventricular hemorrhage in preterm infants.

Related Concept Videos

Two-Compartment Open Model: IV Infusion01:15

Two-Compartment Open Model: IV Infusion

A two-compartment model is a vital tool in pharmacokinetics, providing an essential understanding of drug behavior, especially for those administered via zero-order intravenous infusion. This model outlines two compartments: the central compartment, where elimination occurs, and the peripheral compartment.
The model illustrates the decrease in plasma drug concentration from the central compartment with a specific equation. It shows that under steady-state conditions, the drug's input rate...
573
One-Compartment Model: IV Infusion01:09

One-Compartment Model: IV Infusion

Intravenous (IV) infusion is often utilized when continuous and controlled drug delivery is necessary, such as during surgery or in the treatment of chronic diseases. This method offers numerous advantages, including immediate drug action, precise control over dosage, and bypassing the first-pass metabolism.
The one-compartment model for IV infusion uses mathematical equations to describe the rate of change in drug quantity in the body. At steady-state or infusion equilibrium, the drug input...
498
Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.6K
Embryonic Stem Cells00:58

Embryonic Stem Cells

Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.
32.1K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
14.6K
Adult Stem Cells01:33

Adult Stem Cells

Stem cells are undifferentiated cells that divide and produce more stem cells or progenitor cells that differentiate into mature, specialized cell types. All the cells in the body are generated from stem cells in the early embryo, but small populations of stem cells are also present in many adult tissues including the bone marrow, brain, skin, and gut. These adult stem cells typically produce the various cell types found in that tissue—to replace cells that are damaged or to continuously...
33.4K